We are live on ! Find out more
B

Baird Portfolio holdings

AUM $9.78B
1-Year Est. Return 11.39%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+11.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.12B
AUM Growth
-$7.13M
Cap. Flow
+$96.1M
Cap. Flow %
1.35%
Top 10 Hldgs %
13.48%
Holding
1,248
New
108
Increased
560
Reduced
379
Closed
152

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$42.7M
2
VIAB
Viacom Inc. Class B
VIAB
+$40.6M
3
EOG icon
EOG Resources
EOG
+$35.5M
4
JCI icon
Johnson Controls International
JCI
+$32.5M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$29.5M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$48.9M
2
NSC icon
Norfolk Southern
NSC
+$35.5M
3
HYS icon
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
+$32.1M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$31.6M
5
FLR icon
Fluor
FLR
+$29.2M

Sector Composition

Rank Sector Weight
1 Industrials 12.64%
2 Technology 12.01%
3 Healthcare 10.21%
4 Financials 10.17%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
101
State Street Health Care Select Sector SPDR ETF
XLV
$41.2B
$21M 0.29%
327,851
+313,509
+2,186% +$19.6M
IGIB icon
102
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$20.7M 0.29%
378,780
+78,314
+26% +$4.3M
IWB icon
103
iShares Russell 1000 ETF
IWB
$47.9B
$20.3M 0.29%
185,034
-4,908
-3% -$542K
COP icon
104
ConocoPhillips
COP
$141B
$20M 0.28%
261,028
-22,679
-8% -$1.86M
ATR icon
105
AptarGroup
ATR
$8.29B
$19.9M 0.28%
328,290
-117,637
-26% -$7.48M
CELG
106
DELISTED
Celgene Corp
CELG
$19.8M 0.28%
209,166
-42,130
-17% -$3.8M
NUV icon
107
Nuveen Municipal Value Fund
NUV
$1.92B
$19.8M 0.28%
2,104,687
-1,914
-0.1% -$18K
EVHC
108
DELISTED
Envision Healthcare Holdings Inc
EVHC
$19.8M 0.28%
190,210
+92,699
+95% +$9.83M
IGSB icon
109
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$19.6M 0.28%
372,354
+74,558
+25% +$3.93M
ENV
110
DELISTED
ENVESTNET, INC.
ENV
$19.5M 0.27%
432,770
+224,786
+108% +$10.3M
IVZ icon
111
Invesco
IVZ
$13.1B
$19.3M 0.27%
489,404
+21,304
+5% +$838K
EPAC icon
112
Enerpac Tool Group
EPAC
$1.74B
$19.3M 0.27%
631,321
-223,383
-26% -$7.38M
IJR icon
113
iShares Core S&P Small-Cap ETF
IJR
$109B
$18.4M 0.26%
352,858
+7,174
+2% +$390K
MRK icon
114
Merck
MRK
$307B
$18.4M 0.26%
325,251
-16,817
-5% -$944K
PFF icon
115
iShares Preferred and Income Securities ETF
PFF
$13.3B
$18.4M 0.26%
465,255
-56,981
-11% -$2.26M
SLB icon
116
SLB Ltd
SLB
$69.4B
$18.2M 0.26%
179,377
+10,105
+6% +$1.1M
XLK icon
117
State Street Technology Select Sector SPDR ETF
XLK
$114B
$18M 0.25%
900,510
+289,426
+47% +$5.73M
IVV icon
118
iShares Core S&P 500 ETF
IVV
$879B
$17.9M 0.25%
90,456
+4,327
+5% +$861K
MA icon
119
Mastercard
MA
$484B
$17.9M 0.25%
242,134
+4,427
+2% +$337K
ABBV icon
120
AbbVie
ABBV
$448B
$17.7M 0.25%
305,689
-62,267
-17% -$3.46M
MDY icon
121
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$17.6M 0.25%
70,633
+1,090
+2% +$280K
V icon
122
Visa
V
$686B
$17.6M 0.25%
330,012
+16,892
+5% +$908K
GMED icon
123
Globus Medical
GMED
$10.3B
$17.1M 0.24%
867,840
+30,168
+4% +$621K
AMGN icon
124
Amgen
AMGN
$197B
$16.7M 0.23%
118,768
-15,863
-12% -$2.07M
GILD icon
125
Gilead Sciences
GILD
$165B
$16.5M 0.23%
155,042
-1,670
-1% -$164K
3 4
5
6 7

Similar funds

JCMLC
JAT Capital Management LP (Connecticut) Greenwich, Connecticut $3.72B AUM 19.21% 1-Year Est. Return
CIFMU
Childrens Investment Fund Management (UK) London, United Kingdom $2.75B AUM 16.25% 1-Year Est. Return
BPBT
Boston Private Bank & Trust Boston, Massachusetts $2.17B AUM 12.34% 1-Year Est. Return
RVP
Relative Value Partners Northbrook, Illinois $880M AUM 0.38% 1-Year Est. Return
ICM
ICC Capital Management Orlando, Florida $760M AUM 17.03% 1-Year Est. Return
FAAM
First Allied Asset Management San Diego, California $712M AUM 9.35% 1-Year Est. Return
SAG
Sterne Agee Group Birmingham, Alabama $681M AUM 8.94% 1-Year Est. Return
GIM
Gyrus Investment Management Toronto, Ontario, Canada $604M AUM 14.24% 1-Year Est. Return

Baird's Q3 2014 Portfolio in Review

As of Q3 2014, Baird held 1,248 positions worth $7.12B, down 0.1% from $7.13B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Baird's Q3 2014 filing shows 108 new, 560 increased, 379 reduced and 152 closed positions. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 203,409 shares worth $31.8M. The largest sale was Intel, an estimated $48.9M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

  • Baird's largest Q3 2014 buy was SALIX PHARMACEUTICALS LTD DEL: 203,409 shares worth $31.8M.
  • Baird added most to Oracle in Q3 2014, an estimated $42.7M increase.
  • Baird's biggest Q3 2014 reduction was Intel, cutting an estimated $48.9M.
  • Baird fully exited CONCUR TECHNOLOGIES INC in Q3 2014, selling an estimated $31.6M.
  • Baird's ten largest holdings make up 13% of its $7.12B portfolio in Q3 2014.
  • Baird opened 108 new positions and closed 152 in Q3 2014.
  • Baird's portfolio value fell 0.1% quarter-over-quarter to $7.12B.

Based on Baird's 13F filing for Q3 2014, filed 12 Nov 2014.